Andrea Nye

Immplacate, Inc. is an American company that focuses on researching and developing cell therapies and related products to improve the quality of life for patients with immune disorders. The company was founded by Gordana Vunjak-Novakovic and Holly Wobman, and the CEO is Anthony A Curro.

Spruce Technology, Inc provides information technology solutions and services. Its solutions include Microsoft practice, licensing practice, enterprise resource planning, enterprise content management, project delivery, and business solutions. The firm also provides advisory, professional, and strategic staffing services. Spruce Technology was founded in 2006 and is headquartered in Clifton, NJ.

PhageNova Bio, Inc. is a biotechnology company that is developing a modular, bacteriophage-based platform for targeted gene expression in cancer, vaccination, and molecular imaging. PhageNova Bio is based in Scarsdale, NY. The company's lead cancer construct is designed to selectively target tumor-associated blood vessels and tumor cells, resulting in the expression of TNF-?, an anti-tumor agent, specifically and exclusively in tumors. The company has extensively validated tumor targeting and selective gene expression capabilities, and therapeutic efficacy was observed in the absence of dose-limiting toxicity in multiple species and several tumor models. The company was founded by Renata Pasqualini, Wadih Arap, Steven K. Libutti, Juri G. Gelovani, and the CEO is Jason A. Rifkin.

NanoTomer, Inc. provides bio technology services. The company is headquartered in Boston, MA.

AZTherapies, Inc. engages in the development of therapeutics for Alzheimer’s disease and ischemic stroke treatments. Its product pipelines include ALZT-OP1, ALZT-OP2, AZHALER-D, and ALZT-QoL. The company was founded by David R. Elmaleh in 2011 and is headquartered in Boston, MA.

IQuum, Inc. designs and develops biological molecular diagnostics products. It develops lab-in-a-tube technology, a novel biological sample testing platform which provides revolutionary benefits to a broad cross section of the bioassay market. The firm''s proprietary technology enables the non-specialized personnel to perform more sophisticated biological sample testing in any setting with greater speed. The company was founded by Shuqi Chen and Keith Greenfield in 1998 and is headquartered in Marlborough, MA.

Matritek, Inc. develops tissue specific biomaterials. It offers biomaterial products in the areas of bladder, blood vessel, bone, brain, cartilage, chorion, esophagus, fat, heart, kidney, large intestine, larynx, liver, lung, microvasculature, muscle, pancreas, skin, small intestine, spleen, stomach, thymus, umbilical cord, and other organs. The company was founded by John O'Neill and Sue Halligan in 2016 and is headquartered in New York, NY.

Catalio Capital Management LP (Catalio Capital) is a venture capital firm founded in 2020 by George Petrocheilos and Dr. Jacob Vogelstein. The firm is headquartered in New York.

Epibone, Inc. develops bone reconstruction solutions. Its technology utilizes a scan of the patient?s bone defect and the patient?s own stem cells to construct and cultivate an autologous-like bone graft that provides defect repair, and improves bone formation and regeneration. The company was founded by Nina Tandon, Gordana Vunjak-Novakovic, Sarindr Bhumiratana, Sidney Eisig, and Elisa Cimetta and is headquartered in Brooklyn, NY.

TARA Biosystems, Inc. develops organ-on-a-chip platform. It focuses on cardiac toxicology, heart failure drug discovery and personalized cardiology. The company was founded by Misti Ushio, Milica Radisic, Yimu Zhao, Gordana Vunjak-Novakovic, Kacey Ronaldson, Boyang Zhang and Blake Stevens on October 22, 2014 and is headquartered in New York, NY.

The Doe Fund, Inc. provides programs and support services for homeless people. The private company is based in New York, NY.